Get started
Author

Wenjun Yang

Observed name: Yang, Wenjun
Observed institutions: University of Iowa, University of Wisconsin–Madison, China Three Gorges University, Fudan University, Zhongshan Hospital, Huai'an University, Chongqing Three Gorges University
ORCID: 0009-0006-4168-2548
Observed ORCID: 0009-0006-4168-2548
OpenAlex ID: A5113571981
Rotating-shield brachytherapy for cervical cancer
2013 · Wenjun Yang, Yusung Kim, et al. · Physics in Medicine and Biology · 30
PDF
Application of digital mammography-based radiomics in the differentiation of benign and malignant round-like breast tumors and the prediction of molecular subtypes
2020 · Lanyun Wang, Wenjun Yang, et al. · Gland Surgery · 22
PDF
Post-Procedure Evaluation of Microwave Ablations of Hepatocellular Carcinomas Using Electrode Displacement Elastography
2016 · Wenjun Yang, Timothy J. Ziemlewicz, et al. · Ultrasound in Medicine & Biology · 22
Dynamic rotating‐shield brachytherapy
2013 · Yunlong Liu, Ryan T. Flynn, et al. · Medical Physics · 22
PDF
Delineation of Post-Procedure Ablation Regions with Electrode Displacement Elastography with a Comparison to Acoustic Radiation Force Impulse Imaging
2017 · Wenjun Yang, Tomy Varghese, et al. · Ultrasound in Medicine & Biology · 14
A method for landslide identification and detection in high-precision aerial imagery: progressive CBAM-U-net model
2024 · Hanjie Lin, Li Li, et al. · Earth Science Informatics · 13
Rapid emission angle selection for rotating‐shield brachytherapy
2013 · Yunlong Liu, Ryan T. Flynn, et al. · Medical Physics · 13
Relative Elastic Modulus Imaging Using Sector Ultrasound Data for Abdominal Applications: An Evaluation of Strategies and Feasibility
2016 · Bo Peng, Yu Wang, et al. · IEEE Transactions on Ultrasonics Ferroelectrics and Frequency Control · 12
CD27-Armored BCMA CAR T-cell Therapy (CBG-002) for Relapsed and Refractory Multiple Myeloma: A Phase I Clinical Trial
2024 · Yang Xu, Xuzhao Zhang, et al. · Cancer Immunology Research · 8
Comparison of three dimensional strain volume reconstructions using SOUPR and wobbler based acquisitions: A phantom study
2016 · Wenjun Yang, Atul Ingle, et al. · Medical Physics · 8
PDF
CD27-Armored BCMA-CAR T Cell (CBG-002) Therapy for Relapsed and Refractory Multiple Myeloma: A Phase I Clinical Trial
2023 · Yang Xu, Xuzhao Zhang, et al. · Blood · 6
A Radiomics Nomogram for Distinguishing Benign From Malignant Round-Like Breast Tumors
2022 · Lanyun Wang, Yi Ding, et al. · Frontiers in Oncology · 3
PDF
Comparison study of displacement estimation methods for microwave ablation procedures using electrode displacement elastography
2017 · Robert Pohlman, Jingfeng Jiang, et al. · IEEE International Ultrasonics Symposium · 2
Exploring the effect of soil zoning in the TRIGRS and Scoops3D integrated model on the stability of rainfall-induced shallow landslides
2025 · Siyu Liang, Li Li, et al. · Geomatics Natural Hazards and Risk · 1
Figure S2 from CD27-Armored BCMA CAR T-cell Therapy (CBG-002) for Relapsed and Refractory Multiple Myeloma: A Phase I Clinical Trial
2026 · Yang Xu, Xuzhao Zhang, et al.
Figure S4 from CD27-Armored BCMA CAR T-cell Therapy (CBG-002) for Relapsed and Refractory Multiple Myeloma: A Phase I Clinical Trial
2026 · Yang Xu, Xuzhao Zhang, et al.
Figure S3 from CD27-Armored BCMA CAR T-cell Therapy (CBG-002) for Relapsed and Refractory Multiple Myeloma: A Phase I Clinical Trial
2026 · Yang Xu, Xuzhao Zhang, et al.
Figure S1 from CD27-Armored BCMA CAR T-cell Therapy (CBG-002) for Relapsed and Refractory Multiple Myeloma: A Phase I Clinical Trial
2026 · Yang Xu, Xuzhao Zhang, et al.
Deep-learning-based Radiomics on Mitigating Post-treatment Obesity for Pediatric Craniopharyngioma Patients after Surgery and Proton Therapy
2025 · Yang, Wenjun, Hua, Chia-Ho, et al. · arXiv (Cornell University)
PDF
Table S1 from CD27-Armored BCMA CAR T-cell Therapy (CBG-002) for Relapsed and Refractory Multiple Myeloma: A Phase I Clinical Trial
2025 · Yang Xu, Xuzhao Zhang, et al.
Figure S4 from CD27-Armored BCMA CAR T-cell Therapy (CBG-002) for Relapsed and Refractory Multiple Myeloma: A Phase I Clinical Trial
2025 · Yang Xu, Xuzhao Zhang, et al.
Figure S1 from CD27-Armored BCMA CAR T-cell Therapy (CBG-002) for Relapsed and Refractory Multiple Myeloma: A Phase I Clinical Trial
2025 · Yang Xu, Xuzhao Zhang, et al.
Figure S2 from CD27-Armored BCMA CAR T-cell Therapy (CBG-002) for Relapsed and Refractory Multiple Myeloma: A Phase I Clinical Trial
2025 · Yang Xu, Xuzhao Zhang, et al.
Figure S3 from CD27-Armored BCMA CAR T-cell Therapy (CBG-002) for Relapsed and Refractory Multiple Myeloma: A Phase I Clinical Trial
2025 · Yang Xu, Xuzhao Zhang, et al.
Data from CD27-Armored BCMA CAR T-cell Therapy (CBG-002) for Relapsed and Refractory Multiple Myeloma: A Phase I Clinical Trial
2025 · Yang Xu, Xuzhao Zhang, et al.
Works count: 28
Citation count: 176
H-index: 8
I10-index: 8
Year
Topic
Type